Tang D G, Renaud C, Stojakovic S, Diglio C A, Porter A, Honn K V
Department of Radiation Oncology, Wayne State University, Detroit, MI 48202, USA.
Biochem Biophys Res Commun. 1995 Jun 15;211(2):462-8. doi: 10.1006/bbrc.1995.1836.
12(S)-HETE [12(S)-hydroxyeicosatetraenoic acid] is a lipoxygenase metabolite of arachidonic acid. Treatment of murine-lung-derived microvascular endothelial cells (CD clone 4) with exogenous 12(S)-HETE promoted wound healing of injured endothelial cell monolayers. 12(S)-HETE, in a time- and dose-dependent manner, enhanced the growth of CD clone 4 cells. Thymidine incorporation assays demonstrated that 12(S)-HETE increased the DNA synthesis by > 4 fold. In addition, normal endothelial cell growth stimulated by serum could be dose-dependently inhibited by a select 12-lipoxygenase inhibitor (BHPP), suggesting that 12(S)-HETE is a physiological mitogenic factor for microvascular endothelial cells.
12(S)-羟基二十碳四烯酸[12(S)-hydroxyeicosatetraenoic acid]是花生四烯酸的脂氧合酶代谢产物。用外源性12(S)-羟基二十碳四烯酸处理源自鼠肺的微血管内皮细胞(CD克隆4)可促进受损内皮细胞单层的伤口愈合。12(S)-羟基二十碳四烯酸以时间和剂量依赖性方式增强CD克隆4细胞的生长。胸苷掺入试验表明,12(S)-羟基二十碳四烯酸使DNA合成增加了4倍以上。此外,一种选择性12-脂氧合酶抑制剂(BHPP)可剂量依赖性地抑制血清刺激的正常内皮细胞生长,这表明12(S)-羟基二十碳四烯酸是微血管内皮细胞的一种生理性促有丝分裂因子。